Progenics to Present Results from the Phase 3 CONDOR Trial of PyL™ (18F-DCFPyL) in Prostate Cancer at the American Society of Clinical Oncology 2020 Virtual Scientific Program

NEXT STORY
AXIM® Biotechnologies Files for Patent for Unique Biomarker for Early Detection of Cancer in Blood
PREV STORY
Aegea Biotechnologies, Inc. Announces the Issuance of 7 Additional Key U.S. Patents Relating to its Core, Next Generation Nucleic Acid Clinical Diagnostic Technologies and COVID-19 Test Development
Subscribe now to PM360
Get in touch with PM360 Experts On Call

Experts on Call

Ads

You May Also Like

Aptose Biosciences and CrystalGenomics Announce Issuance of Japanese Patent for CG-806

SAN DIEGO, TORONTO, and SEOUL, July 10, 2018 (GLOBE NEWSWIRE) -- Aptose Biosciences Inc. ...

author_avatar
NASDAQ Market News

Precision Therapeutics Appoints Dr. Amelia Warner to Scientific Advisory Board

MINNEAPOLIS, Sept. 11, 2018 (GLOBE NEWSWIRE) -- Precision Therapeutics Inc. (NASDAQ:AIPT) (“Precision” or “the ...

author_avatar
NASDAQ Market News

Shire Announces FDA Approval of TAKHZYRO™ (lanadelumab-flyo), a First-of-its-Kind mAb Preventive Treatment for Hereditary Angioedema

Shire Announces FDA Approval of TAKHZYRO™ (lanadelumab-flyo), a First-of-its-Kind mAb Preventive Treatment for Hereditary ...

author_avatar
NASDAQ Market News